Annovis Bio, Inc. (ANVS) Operating income 2019–2025
Annovis Bio, Inc. (ANVS) annual operating income history from SEC filings — each fiscal year as reported.
-$29.7MFY2025 · since FY2019: -$1.6M → -$29.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$29.7M | -11.2% |
| FY2024 | -$26.7M | +40.7% |
| FY2023 | -$45.0M | -76.5% |
| FY2022 | -$25.5M | -75.5% |
| FY2021 | -$14.5M | -118.9% |
| FY2020 | -$6.6M | -313.6% |
| FY2019 | -$1.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice